Joana Cartocci

Co-founder and Chief Operating Officer of Robeauté, a Paris-based neurotechnology company developing microrobotic tools for minimally invasive brain diagnosis, treatment, and monitoring. She is an operations and deeptech leader and a former FranceBiotech board member.

Robeauté Targets 2027 Human Trials for Brain Microrobot

Robeauté is developing rice-sized microrobots that it says could navigate through brain tissue to collect biopsies or deliver therapies directly to hard-to-reach sites. Chief executive Joana Cartocci argues that advances in drugs, gene therapies and AI will remain limited unless they can be placed precisely in the brain, bypassing obstacles such as the blood-brain barrier. The French startup plans to begin with advanced tumor biopsy in first-in-human studies targeted for 2027, before expanding to other uses.

Bloomberg TechnologyAug 17, 20263 min read